#USA #LabConnect #Johnson City #Radiopharmaceutical #Bracken Group

LabConnect and The Bracken Group Join Forces to Enhance Radiopharmaceutical Services

In a significant development for the healthcare and clinical trial sectors, LabConnect, a renowned provider of central laboratory and clinical trial support services, has announced a strategic collaboration with The Bracken Group. This partnership aims to expand LabConnect's capabilities in offering radiopharmaceutical support as the demand for such services continues to grow at an annual rate of 15 to 20%.

Addressing Growing Industry Needs

The increasing prevalence of biotechnological and pharmaceutical advancements necessitates enhanced support for radiopharmaceuticals, particularly in the areas of diagnostics and treatment. LabConnect's CEO, Wes Wheeler, emphasized the importance of this collaboration, stating that it allows the company to better meet the complex logistical and analytical challenges faced by clients engaged in clinical trials involving radiopharmaceuticals.

The Bracken Group, heralded as a leader in the radiopharmaceutical sector, brings unmatched scientific insight and regulatory expertise that is vital for the development, regulation, and commercialization of these products. Their extensive background ensures that LabConnect can provide even more robust support to its clients.

Unique Integration of Expertise

According to Colin Miller, PhD, CEO of The Bracken Group, the union of their scientific prowess and LabConnect’s operational excellence creates an unprecedented opportunity in the sector. He noted the importance of bridging the gap between medicine, science, and operations, a goal they aim to achieve through this partnership.

The collaboration will focus on several critical areas, including sample processing, logistics, and scientific oversight. These components are vital given the complex and highly regulated nature of radiopharmaceuticals.

Strengthening Operations

This partnership is not only about expanding service offerings; it also aims to enhance the quality of service delivery. LabConnect has established a strong reputation for its innovative solutions, driven by state-of-the-art technology and top-tier laboratories. The company’s unique combination of easy access to major and emerging markets, alongside extensive experience in specialized testing, positions it as a comprehensive solution provider for drug development companies.

About LabConnect

LabConnect, LLC has been a leader in providing central laboratory services, FSP, scientific consulting, and data integration and transformation for analytically and logistically complex studies. Their expertise spans across various challenging fields such as immuno-oncology, cellular and genetic therapies, and rare diseases.

For more information, visit LabConnect.com or follow them on LinkedIn.

About The Bracken Group

The Bracken Group offers consulting, regulatory, analytical, marketing, and sales enablement solutions for the life sciences and digital health industries. With a team of seasoned consultants and data-driven business programs, Bracken employs a multidisciplinary approach to exceed their clients’ goals.

Learn more at TheBrackenGroup.com and follow them on LinkedIn.

Through this alliance, LabConnect and The Bracken Group aim to redefine standards in the radiopharmaceutical support services industry, thereby enhancing patient care and treatment outcomes across the globe.